Adherex Technologies (FENC) Competitors $8.96 -0.37 (-3.97%) As of 11:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FENC vs. COLL, IMNM, RAPP, SPRY, UPB, CRON, NBTX, VALN, PGEN, and SYREShould you be buying Adherex Technologies stock or one of its competitors? The main competitors of Adherex Technologies include Collegium Pharmaceutical (COLL), Immunome (IMNM), Rapport Therapeutics (RAPP), ARS Pharmaceuticals (SPRY), Upstream Bio (UPB), Cronos Group (CRON), Nanobiotix (NBTX), Valneva (VALN), Precigen (PGEN), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. Adherex Technologies vs. Its Competitors Collegium Pharmaceutical Immunome Rapport Therapeutics ARS Pharmaceuticals Upstream Bio Cronos Group Nanobiotix Valneva Precigen Spyre Therapeutics Collegium Pharmaceutical (NASDAQ:COLL) and Adherex Technologies (NASDAQ:FENC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk. Is COLL or FENC more profitable? Collegium Pharmaceutical has a net margin of 5.13% compared to Adherex Technologies' net margin of -35.05%. Collegium Pharmaceutical's return on equity of 97.28% beat Adherex Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Collegium Pharmaceutical5.13% 97.28% 13.87% Adherex Technologies -35.05%N/A -23.92% Does the media refer more to COLL or FENC? In the previous week, Adherex Technologies had 9 more articles in the media than Collegium Pharmaceutical. MarketBeat recorded 14 mentions for Adherex Technologies and 5 mentions for Collegium Pharmaceutical. Collegium Pharmaceutical's average media sentiment score of 0.99 beat Adherex Technologies' score of 0.72 indicating that Collegium Pharmaceutical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Collegium Pharmaceutical 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adherex Technologies 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer COLL or FENC? Collegium Pharmaceutical presently has a consensus price target of $42.33, indicating a potential upside of 31.49%. Adherex Technologies has a consensus price target of $13.33, indicating a potential upside of 48.81%. Given Adherex Technologies' higher probable upside, analysts clearly believe Adherex Technologies is more favorable than Collegium Pharmaceutical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Collegium Pharmaceutical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.00Adherex Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.67 Which has better valuation and earnings, COLL or FENC? Collegium Pharmaceutical has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Collegium Pharmaceutical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollegium Pharmaceutical$707.01M1.43$69.19M$1.0430.96Adherex Technologies$33.30M7.51-$440K-$0.42-21.33 Do insiders & institutionals believe in COLL or FENC? 55.5% of Adherex Technologies shares are held by institutional investors. 2.5% of Collegium Pharmaceutical shares are held by company insiders. Comparatively, 11.8% of Adherex Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, COLL or FENC? Collegium Pharmaceutical has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Comparatively, Adherex Technologies has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. SummaryCollegium Pharmaceutical beats Adherex Technologies on 11 of the 17 factors compared between the two stocks. Get Adherex Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FENC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FENC vs. The Competition Export to ExcelMetricAdherex TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$250.53M$3.36B$6.12B$10.61BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-21.3722.1885.8427.37Price / Sales7.51411.46584.84180.95Price / Cash285.4947.1938.3262.20Price / Book-42.6710.3212.806.73Net Income-$440K-$52.40M$3.30B$275.87M7 Day Performance-9.31%2.84%2.75%1.39%1 Month Performance-0.55%14.48%9.44%8.31%1 Year Performance113.84%31.47%81.30%35.58% Adherex Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FENCAdherex Technologies2.1024 of 5 stars$8.96-4.0%$13.33+48.8%+119.0%$250.08M$33.30M-21.3310News CoverageAnalyst ForecastInsider TradeCOLLCollegium Pharmaceutical4.1788 of 5 stars$33.83-2.3%$42.33+25.1%-11.6%$1.09B$707.01M32.53210Analyst ForecastIMNMImmunome1.6756 of 5 stars$14.41+16.4%$23.20+61.0%+16.2%$1.08B$9.04M-4.6840Analyst ForecastGap UpRAPPRapport Therapeutics2.7998 of 5 stars$27.74-2.8%$35.33+27.4%+37.2%$1.04BN/A-11.10N/AAnalyst ForecastSPRYARS Pharmaceuticals2.8655 of 5 stars$10.27-0.4%$33.17+222.9%-15.5%$1.02B$89.15M-20.9690Analyst ForecastUPBUpstream Bio1.8302 of 5 stars$18.97+1.8%$56.50+197.8%N/A$1.00B$2.37M0.0038Analyst ForecastCRONCronos Group1.6616 of 5 stars$2.55-1.2%N/A+27.8%$987.86M$117.61M51.00450News CoverageAnalyst ForecastGap UpNBTXNanobiotix1.2106 of 5 stars$22.78+11.1%$11.00-51.7%+492.3%$983.31M$39.18M0.00100Analyst ForecastGap DownVALNValneva2.3614 of 5 stars$11.02-3.2%$15.00+36.1%+92.1%$978.71M$183.52M-11.24700Analyst ForecastGap DownPGENPrecigen4.4996 of 5 stars$3.14-3.4%$8.25+162.7%+275.3%$968.41M$3.92M-7.48190Analyst ForecastGap UpSYRESpyre Therapeutics3.2266 of 5 stars$16.67+4.9%$54.29+225.6%-23.0%$959.77M$890K-4.9073Analyst Forecast Related Companies and Tools Related Companies Collegium Pharmaceutical Alternatives Immunome Alternatives Rapport Therapeutics Alternatives ARS Pharmaceuticals Alternatives Upstream Bio Alternatives Cronos Group Alternatives Nanobiotix Alternatives Valneva Alternatives Precigen Alternatives Spyre Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FENC) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersWhy This Titanium Explorer Caught Rio Tinto’s EyeAs U.S. defense spending crosses $1 trillion, drones, hypersonics, and next-gen aerospace are taking center st...Capital Trends | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
